These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes). Gerö L, Korányi L, Tamás G. Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742 [Abstract] [Full Text] [Related]
7. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ. Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [Abstract] [Full Text] [Related]
8. The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy. Greco AV, Caputo S, Bertoli A, Ghirlanda G. Horm Metab Res; 1992 Jun; 24(6):280-3. PubMed ID: 1634193 [Abstract] [Full Text] [Related]
16. Beta cell function in insulin-treated non-insulin-dependent diabetic patients. Ramachandran A, Snehalatha C, Mohan V, Rao CA, Viswanathan M. Pancreas; 1986 Jun; 1(5):411-4. PubMed ID: 3550785 [Abstract] [Full Text] [Related]
17. The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes. Gjessing HJ, Damsgaard EM, Matzen LE, Faber OK, Frøland A. Scand J Clin Lab Invest; 1988 Dec; 48(8):771-7. PubMed ID: 3070718 [Abstract] [Full Text] [Related]
18. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients. Hsieh SD, Kanazawa Y, Akanuma Y. Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258 [Abstract] [Full Text] [Related]